Evidence map›Paper›PMID 15767455›Full record

ArticleJournal of virology2005

The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.

Kirilee A Wilson, Séverine Bär, Anne L Maerz, Marc Alizon, Pantelis Poumbourios

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Linkers in the structural biology of protein-protein interactions.Protein science : a publication of the Protein Society · 2013
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Viral pathogenesis, modulation of immune receptor signaling and treatment.Advances in experimental medicine and biology · 2008
    Review
  11. SCHOOL model and new targeting strategies.Advances in experimental medicine and biology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kirilee A WilsonSt. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Séverine Bär
Anne L Maerz
Marc Alizon
Pantelis Poumbourios
St Vincents Institute of Medical Research · AUInstitut Cochin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retroviral transmembrane proteins (TMs) contain an N-terminal fusion peptide that initiates virus-cell membrane fusion. The fusion peptide is linked to the coiled-coil core through a conserved sequence that is often rich in glycines. We investigated the functional role of the glycine-rich segment, Met-326 to Ser-337, of the human T-cell leukemia virus type 1 (HTLV-1) TM, gp21, by alanine and proline scanning mutagenesis. Alanine substitution for the hydrophobic residue Ile-334 caused an approximately 90% reduction in cell-cell fusion activity without detectable effects on the lipid-mixing and pore formation phases of fusion. Alanine substitutions at other positions had smaller effects (Gly-329, Val-330, and Gly-332) or no effect on fusion function. Proline substitution for glycine residues inhibited cell-cell fusion function with position-dependent effects on the three phases of fusion. Retroviral glycoprotein fusion function thus appears to require flexibility within the glycine-rich segment and hydrophobic contacts mediated by this segment.

Indexed as

Membrane FusionProtein Structure, TertiaryAmino Acid Substitutionenv Gene Products, Human Immunodeficiency VirusGene Products, envHuman T-lymphotropic virus 1Mutagenesis, Site-DirectedMutationRetroviridae Proteins, Oncogenicenv Gene Products, Human Immunodeficiency VirusGene Products, envgp21 protein, Human T-lymphotropic virus 1Retroviridae Proteins, Oncogenic

Identifiers

PMID15767455
PMCPMC1061562
OpenAlexW1983520824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.